🇺🇸 FDA
Pipeline program

PCV21

PSK00010

Phase 3 mab active

Quick answer

PCV21 for Pneumococcal Infections is a Phase 3 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Pneumococcal Infections
Phase
Phase 3
Modality
mab
Status
active

Clinical trials